[go: up one dir, main page]

BR9714382A - 17alpha-dihydroequiline for use as a medical antioxidant - Google Patents

17alpha-dihydroequiline for use as a medical antioxidant

Info

Publication number
BR9714382A
BR9714382A BR9714382-0A BR9714382A BR9714382A BR 9714382 A BR9714382 A BR 9714382A BR 9714382 A BR9714382 A BR 9714382A BR 9714382 A BR9714382 A BR 9714382A
Authority
BR
Brazil
Prior art keywords
17alpha
dihydroequiline
antioxidant
medical
medical antioxidant
Prior art date
Application number
BR9714382-0A
Other languages
Portuguese (pt)
Inventor
Steven Jay Adelman
Dorothy Helen Prozialeck
Donald Eugene Clarck
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9714382A publication Critical patent/BR9714382A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"17ALFA-DIIDROEQUILENINA PARA USO COMO UM ANTIOXIDANTE MéDICO"<D>. A presente invenção fornece um método de usar 17<244>-diidroequilenina ou um sal farmaceuticamente aceitável de éster de 17<244>-diidroequilenina-3-sulfato como um antioxidante.Invention Patent: <B> "17ALPHA-DIIDROEQUILENINE FOR USE AS A MEDICAL ANTIOXIDANT" <D>. The present invention provides a method of using 17 <244> -dihydroequilenin or a pharmaceutically acceptable salt of 17 <244> -dihydroequilenin-3-sulfate as an antioxidant.

BR9714382-0A 1996-12-09 1997-12-05 17alpha-dihydroequiline for use as a medical antioxidant BR9714382A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76263496A 1996-12-09 1996-12-09
PCT/US1997/022155 WO1998025627A1 (en) 1996-12-09 1997-12-05 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT

Publications (1)

Publication Number Publication Date
BR9714382A true BR9714382A (en) 2000-05-16

Family

ID=25065657

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714382-0A BR9714382A (en) 1996-12-09 1997-12-05 17alpha-dihydroequiline for use as a medical antioxidant

Country Status (13)

Country Link
EP (1) EP0946182A1 (en)
JP (1) JP2001506629A (en)
KR (1) KR20000069346A (en)
CN (1) CN1239890A (en)
AR (1) AR010336A1 (en)
AU (1) AU743519B2 (en)
BR (1) BR9714382A (en)
CA (1) CA2272089A1 (en)
HU (1) HUP0000570A3 (en)
IL (1) IL130069A0 (en)
NZ (1) NZ336341A (en)
WO (1) WO1998025627A1 (en)
ZA (1) ZA9711053B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271221B1 (en) * 1996-12-10 2001-08-07 American Home Products Corporation Use of equilenin as an antioxidant
DE10154221A1 (en) * 2001-11-07 2003-05-15 Max Delbrueck Centrum Agent for the treatment of lesions of the nervous system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4338314C1 (en) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmaceutical preparations for the prophylaxis and therapy of radical-mediated cell damage

Also Published As

Publication number Publication date
NZ336341A (en) 2002-02-01
ZA9711053B (en) 1999-06-09
KR20000069346A (en) 2000-11-25
AR010336A1 (en) 2000-06-07
WO1998025627A1 (en) 1998-06-18
EP0946182A1 (en) 1999-10-06
HUP0000570A2 (en) 2000-10-28
CA2272089A1 (en) 1998-06-18
HUP0000570A3 (en) 2000-12-28
AU5464498A (en) 1998-07-03
IL130069A0 (en) 2000-02-29
JP2001506629A (en) 2001-05-22
AU743519B2 (en) 2002-01-31
CN1239890A (en) 1999-12-29

Similar Documents

Publication Publication Date Title
ES2138691T3 (en) PROCEDURE FOR THE OBTAINING OF DERIVATIVES OF N-ACIL-5-FLUOROCITIDINA.
BR9902086A (en) Pharmaceutical formulations.
HN1997000072A (en) PROCEDURE FOR THE PREPARATION OF SILDENAFIL
AU3153097A (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
BR9408407A (en) Use of pla2 inhibitors as treatment for alzheimer&#39;s disease
BR0109703A (en) Piperazine Derivatives
PL343156A1 (en) Method for stabilizing pharmaceutical compositions by special use of an antioxidant
EA199800667A1 (en) NEW PHENANTRIDINES
WO2001019829A3 (en) Pyrazolopyrimidines as therapeutic agents
AU6613896A (en) Chemical compounds
CU23260B7 (en) MOXIFLOXACINE PHARMACEUTICAL PREPARATION
BR0012429A (en) Formulations for il-11
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
MX9704037A (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
DE60312736D1 (en) 1,2,4-TRIAMINOBENZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
BR9813817A (en) Hemiasterline analogs
MX9704034A (en) DERIVATIVES AND COMPOSITIONS OF SUBSTITUTED 2-ARYLCARBONYLOXYMETHYL-1,2,5-TIADIAZOLIDIN-3-ONA 1,1-DIOXIDE AND METHOD OF USE.
GB9907571D0 (en) Compounds
BR9814495A (en) Compound, process to prepare it, use of it, pharmaceutical composition, and, process
BR9713176A (en) Amorphous benzothiophenes, methods of preparation and methods of use
ATE330958T1 (en) PYRAZINO 1&#39;2&#39;:1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES
WO2003004517A3 (en) Peyers&#39;s patch and/or m-celle targeting ligands
BR9714382A (en) 17alpha-dihydroequiline for use as a medical antioxidant
NO20005548L (en) Mykobakterieinhibitorer
BR9714384A (en) Use of equeilenina as an antioxidant

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25D Requested change of name of applicant approved
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 3A E 7A ANUIDADES.